Alexander Muik
18PUBLICATIONS
87CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (18)
Sort by Publication Date:
|Dec 05, 2025
Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines.Wei Chen, Kristin R Tompkins, Ian W Windsor
|Nov 20, 2024
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine.Kayvon Modjarrad, Ye Che, Wei Chen
|Nov 15, 2022
Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice.Alexander Muik, Bonny Gaby Lui, Maren Bacher
|Sep 20, 2022
Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5.Alexander Muik, Bonny Gaby Lui, Maren Bacher
|Jun 23, 2022
Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine.Chaitanya Kurhade, Jing Zou, Hongjie Xia
|Jun 02, 2022
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes.Jasmin Quandt, Alexander Muik, Nadine Salisch
Pageof 3
Frequent Collaborators
12 joint publications
Ugur Sahin
9 joint publications
Kena A Swanson
8 joint publications
Pei-Yong Shi
6 joint publications
Philip R Dormitzer
5 joint publications
Isabel Vogler
5 joint publications
Mathias Vormehr
5 joint publications
Jasmin Quandt
4 joint publications
Kristen Pascal
4 joint publications
Rolf Hilker
4 joint publications
Martin Bexon
